EFICÁCIA DA ESTIMULAÇÃO MAGNÉTICA TRANSCRANIANA PARA O TRATAMENTO DO TRANSTORNO DEPRESSIVO RESISTENTE: Uma revisão integrativa
Open Access
- 9 January 2025
- journal article
- Published by Psicologia e Saude em Debate in Psicologia e Saúde em Debate
- Vol. 11 (1) , 517-536
Abstract
Major Depressive Disorder (MDD) is alarming due to its high mortality rates and its prevalence in the world population, and, once it does not respond adequately to traditional treatment, the disorder can become a Treatment Resistant Depression (TRD). Among the recommended neurostimulation methods for treatment, Transcranial Magnetic Stimulation (TMS) stands out, as a non-invasive neuromodulation technique directed to the left dorsolateral prefrontal cortex (DLPFC). The main objectives of the work were to evaluate the efficacy of TMS in the treatment of TRD, to investigate its association with other treatments and to investigate the scope of existing studies on the subject. The present Integrative Literature Review extracted data from the SciELO, PubMed and Scopus databases, with the descriptors "Transcranial Magnetic Stimulation", "Depression" and "Efficacy", including experimental, clinical, double-blind, single-blind, placebo-controlled, cohort studies, among others. It was observed among the selected articles that, in the studied populations (between 12 and 78 years), the use of TMS for the treatment of TRD is effective and safe for reducing symptoms, with different applications being tested (application frequency, intensity and time) and their interactions with antidepressants, presenting no contraindications. The results found corroborate with other more recent studies on the subject. Finally, TMS is an effective technique for the treatment of TRD in a safe way for different populations, being recommended for the reduction of depressive symptoms and improvement of the quality of life of those living with the disorder.Keywords
This publication has 33 references indexed in Scilit:
- Real-world retrospective study of repetitive transcranial magnetic stimulation (TMS) treatment for bipolar and unipolar depression using TMS registry data in TokyoHeliyon, 2024
- Dosing transcranial magnetic stimulation in major depressive disorder: Relations between number of treatment sessions and effectiveness in a large patient registryBrain Stimulation, 2023
- Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventionsWorld Psychiatry, 2023
- Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorderDepression and Anxiety, 2022
- Prevalence and Impact of Treatment-Resistant Depression in Latin America: a Prospective, Observational StudyPsychiatric Quarterly, 2021
- Longitudinal effects of rTMS on neuroplasticity in chronic treatment-resistant depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 2020
- Effectiveness of high‐frequency left prefrontal repetitive transcranial magnetic stimulation in patients with treatment‐resistant depression: A randomized clinical trial of 37.5‐minute vs 18.75‐minute protocolNeuropsychopharmacology Reports, 2019
- A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depressionBrain Stimulation, 2012
- The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortexBehavioural Brain Research, 2009
- Hypofrontality in major depressive disorder: Relationship to psychiatric symptomsBiological Psychiatry, 1996